Description
Druphagan is indicated as mono-therapy for the lowering of intraocular pressure (OP) in patients with open angle glaucoma or ocular hypertension who are known or thought likely to be intolerant of topical beta-blocker therapy and or in whom topical beta-blocker therapy is contraindicated
Reviews
There are no reviews yet.